INTRODUCTION {#sec1-1}
============

Microorganisms play a key role in the development of pulpal and periapical diseases. Pulpal diseases leading to inflammation of periapical tissues show the presence of bacteria in the root canal system. Teeth with pulpal or periapical pathology have a complex microbial flora consisting of cocci, rods, spirochetes, and fungi.\[[@ref1]\] Studies have shown that there is a difference between the microbial flora of root canal in cases of primary endodontic infection and in cases of reinfection.\[[@ref2]\] The microorganisms in retreatment cases possess greater resistance to intracanal medicaments. Also, it is found that microbes not only grow in planktonic cells or in aggregates but also forms biofilms.\[[@ref3]\] It was in 1894 when WD Miller first published his observations on microflora. Since then studies have shown that the endodontic environment is selective and it supports the specific microorganisms to grow.\[[@ref4]\]

Later, Fabricius *et al*., in 1982 showed that strict anaerobes succeed over facultative anaerobes in root canal due to changes in root canal ecology.\[[@ref5]\] Studies have also shown that in post treatment diseased teeth, gram positive microorganisms predominate.\[[@ref6][@ref7]\] Some of these microorganisms have the capability to survive in harsh and nutrient limited condition in root canal filled teeth. Teeth with persistent disease showed a high prevalence of Enterococci ranging from 29 to 77%.\[[@ref8][@ref9]\] *Enterococcus faecalis* can withstand high pH of intracanal dressings like calcium hydroxide, and is hence found in higher concentration in reinfection cases.\[[@ref10]\]

The other common organism which persists in post treatment apical pathology is *Candida albicans*.\[[@ref9]\] These resemble Enterococci in some characteristics. Both these organisms can survive as monoinfection and invade dentinal tubules.\[[@ref11]\] Hence, amongst the 24 million endodontic treatment performed on an annual basis, 5.5% procedures involve endodontic surgery and perforation repair.\[[@ref12]\]

When endodontic surgeries are performed at the apex, it involves placement of the material at apical end of the root to seal the root canal from the periapex. Historically, a plethora of materials have been used from amalgam, zinc oxide eugenol, composite resins, and glass ionomer cements.\[[@ref13]\] Unfortunately these materials failed to satisfy the ideal requirements of root-end filling material.\[[@ref14]\] Later in 1990s, mineral trioxide aggregate (MTA) was introduced as a root-end filling material. Till date it is being used as a material of choice for root-end filling. MTA has wide applications in operative dentistry and endodontics. MTA has the disadvantages of long setting time and poor handling properties.\[[@ref15][@ref16]\]

Recently, two new materials have been introduced into market, namely, MTA like material MTA Plus (compounded by Prevest Denpro, Jammu, India for Avalon Biomed, Inc USA) and a calcium silicate based material Biodentine (Septodont, Saint-Maur-des-Fosses, France). Manufacturers claim that these materials can be used as a root-end filling material.

Thus, the aim of the study is to evaluate and compare the antimicrobial efficacy of ProRoot MTA, MTA Plus, and Biodentine against the *E. faecalis* and *C. albicans*.

MATERIALS AND METHODS {#sec1-2}
=====================

The materials evaluated for antimicrobial efficacy were ProRoot MTA (Dentsply), MTA Plus (compounded by Prevest Denpro, Jammu, India for Avalon Biomed, Inc USA), and Biodentine (Septodont, Saint-Maur-des-Fosses, France).

Two hundred milligrams of the material was dissolved in 20 ml of sterile Brain Heart Infusion (BHI) broth. This solution now contained 10 mg of material in 1 ml of broth and is called master dilution. Nine test tubes were arranged in a row. Further dilutions were prepared from tube no. 2 to 6 such that subsequent test tubes had half the concentration of material than the previous. Hence, tube no. 6 had the concentration of 0.156 mg/ml.

Ten microliter of standardized *E. faecalis* was added to tube no. 1-6 and tube no. 8. Tube no. 7 was used to check for sterility of the material. Tube no. 8 and 9 were used as positive and negative control, respectively. The tubes were then incubated at 35°C. Subcultures from each of the tubes were made on Mac Conkey\'s agar and read at the end of 24, 48, and 72 h of incubation. Ten different strains of *E. faecalis* were used for evaluation of antibacterial efficacy of the materials in a similar manner.

For antifungal efficacy, similar methodology was followed. Sabouraud\'s dextrose broth (SDB) and Sabouraud\'s dextrose agar (SDA) was used for dilutions and culture, respectively. Ten different strains of *C. albicans* were used for evaluation of antifungal efficacy of the materials.

The results were tabulated and statistically analyzed using one-way analysis of variance (ANOVA) and Scheffe\'s *post-hoc* tests using Statistical Package for Social Sciences (SPSS) 20\#.

RESULTS {#sec1-3}
=======

Results of antimicrobial efficacy were evaluated between different time intervals andbetween different materials using one-way ANOVA followed by Scheffe\'s *post-hoc* test.

Antibacterial efficacy {#sec2-1}
----------------------

There was a statistically significant difference between the materials at all time intervals (24, 48, and 72 h) with *P*-value 0.019, 0.000, and 0.043, respectively \[[Table 1](#T1){ref-type="table"}\]. Scheffe\'s *post-hoc* test revealed that there was statistically significant difference between Biodentine and MTA Plus at 24 and 48 h with *P*-value of 0.022 and 0.002, respectively. Biodentine showed statistically significant difference with ProRootMTA at 48 h with *P*-value 0.000.

###### 

One-way ANOVA test between three materials at different time intervals
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ProRootMTA showed statistically significant difference at different time intervals with *P*-value 0.001 \[[Table 2](#T2){ref-type="table"}\]. Scheffe\'s *post-hoc* tests revealed there was statistically significant difference in antibacterial efficacy of ProRoot MTA between 24 and 48 h (*P*-value 0.04) and between 24 and 72 h (*P*-value 0.004). There was statistically no significant difference for Biodentine and MTA Plus at different time intervals.

###### 

One-way ANOVA test for materials between different time intervals
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Antifungal efficacy {#sec2-2}
-------------------

There was no statistically significant difference between MTA Plus, Biodentine, and MTA at all time intervals (24, 48, and 72 h).

DISCUSSION {#sec1-4}
==========

The most common method for assessing the antimicrobial activity of root-end filling materials is agar diffusion test. However, this method has disadvantages like lack of standardization of inoculums density, adequate culture medium, agar viscosity, etc.\[[@ref17][@ref18]\] In this study, tube dilution method was used to evaluate the antimicrobial efficacy of the materials. It is an efficient method for evaluating as there is a direct contact between the microorganisms and experimental materials which allows a more realistic interaction.\[[@ref19]\] Various dilutions of the material are prepared and the concentration at which the material was able to inhibit the growth of microorganism was recorded as the minimal inhibitory concentration (MIC) of the material.

The results of antibacterial efficacy against *E. faecalis* showed that ProRoot MTA and Biodentine inhibited the growth of majority of strains of *E. faecalis*; whereas, MTA Plus was not that effective. The MIC at which ProRoot MTA and Biodentine were effective in inhibiting *E. faecalis* is 5 mg/ml. Whereas, MTA Plus inhibited a few strains at 10 mg/ml. For antifungal efficacy, there was no statistically significant difference between ProRoot MTA, MTA Plus, and Biodentine. The MIC at which ProRoot MTA, MTA Plus, and Biodentine were effective in inhibiting *C. albicans* is 2.5 mg/ml.

The antimicrobial efficacy of ProRoot MTA is due to release of calcium ions and hydroxyl ions which results in increase in pH.\[[@ref20][@ref21][@ref22]\] This release of calcium is when calcium silicate gets hydrated and calcium hydroxide is released as a byproduct. Also, the dissociation of calcium hydroxide leads to release of calcium ions. The antimicrobial effect of ProRoot MTA against *E. faecalis* and *C. albicans* obtained in this study is similar to other studies.\[[@ref23]\]

MTA Plus is available in the powder form which is sealed in a desiccant container. It consists of tricalcium silicate, dicalcium silicate, bismuth oxide calcium sulfate, and silica. It can be mixed with either water or an antiwashout gel. On hydration of MTA Plus, strong peak of calcium hydroxide was elicited. A study has shown increased calcium ion release over time. The release of calcium ions and subsequent increase in pH leading to alkaline nature of the material is significant only after 7 and 14 days.\[[@ref24]\] This could be the reason why MTA Plus did not prove to have a good antibacterial property. But it proved to have good antifungal property.

A calcium silicate-based material Biodentine was introduced in 2010 by Gilles and Olivier. Biodentine showed higher release of free calcium ions when compared with ProRoot MTA, and hence higher alkalinizing capacity. The high release of calcium in Biodentine is attributed to presence of calcium silicate and calcium chloride.\[[@ref25]\] Biodentine proved to have a better antibacterial and antifungal property.

CONCLUSION {#sec1-5}
==========

Within the limitations of the study, ProRoot MTA and Biodentine proved to have antifungal and antibacterial property. This study shows that MTA plus was a good antifungal agent, but not an efficient antibacterial. The antibacterial activity of MTA Plus will probably be good at a higher concentration.
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